The DOI matches its Crossref record; 38 of the 41 references it cites were found in a registry or an index.
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Open accessAbstract
Background The long-term health consequences of COVID-19 remain largely unclear. The aim of this study was to describe the long-term health consequences of patients with COVID-19 who have been discharged from hospital and investigate the associated risk factors, in particular disease severity.Methods We did an ambidirectional cohort study of patients with confirmed COVID-19 who had been discharged from Jin Yin-tan Hospital (Wuhan, China) between Jan 7, 2020, and May 29, 2020. Patients who died before follow-up, patients for whom follow-up would be difficult because of psychotic disorders, dementia, or re-admission to hospital, those who were unable to move freely due to concomitant osteoarthropathy or immobile before or after discharge due to diseases such as stroke or pulmonary embolism, those who declined to participate, those who could not be contacted, and those living outside of Wuhan or in nursing or welfare homes were all excluded. All patients were interviewed with a series of questionnaires for evaluation of symptoms and health-related quality of life, underwent physical examinations and a 6-min walking test, and received blood tests. A stratified sampling procedure was used to sample patients according to their highest seven-category scale during their hospital stay as 3, 4, and 5-6, to receive pulmonary function test, high resolution CT of the chest, and ultrasonography. Enrolled patients who had participated in the Lopinavir Trial for Suppression of SARS-CoV-2 in China received severe acute respiratory syndrome coronavirus 2 antibody tests. Multivariable adjusted linear or logistic regression models were used to evaluate the association between disease severity and long-term health consequences.Findings In total, 1733 of 2469 discharged patients with COVID-19 were enrolled after 736 were excluded. Patients had a median age of 57·0 (IQR 47·0-65·0) years and 897 (52%) were men. The follow-up study was done from June 16, to Sept 3, 2020, and the median follow-up time after symptom onset was 186·0 (175·0-199·0) days. Fatigue or muscle weakness (63%, 1038 of 1655) and sleep difficulties (26%, 437 of 1655) were the most common symptoms. Anxiety or depression was reported among 23% (367 of 1617) of patients. The proportions of median 6-min walking distance less than the lower limit of the normal range were 24% for those at severity scale 3, 22% for severity scale 4, and 29% for severity scale 5-6. The corresponding proportions of patients with diffusion impairment were 22% for severity scale 3, 29% for scale 4, and 56% for scale 5-6, and median CT scores were 3·0 (IQR 2·0-5·0) for severity scale 3, 4·0 (3·0-5·0) for scale 4, and 5·0 (4·0-6·0) for scale 5-6. After multivariable adjustment, patients showed an odds ratio (OR) 1·61 (95% CI 0·80-3·25) for scale 4 versus scale 3 and 4·60 (1·85-11·48) for scale 5-6 versus scale 3 for diffusion impairment; OR 0·88 (0·66-1·17) for scale 4 versus scale 3 and OR 1·77 (1·05-2·97) for scale 5-6 versus scale 3 for anxiety or depression, and OR 0·74 (0·58-0·96) for scale 4 versus scale 3 and 2·69 (1·46-4·96) for scale 5-6 versus scale 3 for fatigue or muscle weakness. Of 94 patients with blood antibodies tested at follow-up, the seropositivity (96·2% vs 58·5%) and median titres (19·0 vs 10·0) of the neutralising antibodies were significantly lower compared with at the acute phase. 107 of 822 participants without acute kidney injury and with estimated glomerular filtration rate (eGFR) 90 mL/min per 1·73 m 2 or more at acute phase had eGFR less than 90 mL/min per 1·73 m 2 at follow-up.Interpretation At 6 months after acute infection, COVID-19 survivors were mainly troubled with fatigue or muscle weakness, sleep difficulties, and anxiety or depression. Patients who were more severely ill during their hospital stay had more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, and are the main target population for intervention of long-term recovery.Funding National Natural Science Foundation of China, Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences, National Key Research and Development Program of China, Major Projects of National Science and Technology on New Drug Creation and Development of Pulmonary Tuberculosis, and Peking Union Medical College Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These mental health symptoms persist even after the acute stage of the disease.”
From Psychological treatments for the mental health symptoms among individuals infected with COVID-19: a scoping review protocol (2023) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Further, severe lung complications from COVID-19 may have persisting limitations to respiratory function and gas exchange; this group of patients, therefore, should be the primary target population for the intervention of long-term recovery.”
From Effects of short-term breathing exercises on respiratory recovery in patients with COVID-19: a quasi-experimental study (2022) · cites this paper as [32]
The cited source says what the claim attributes to it.
In the citing paper
“Abdominal chest imaging, and severe impairment to pulmonary diffusion capacities was reported in COVID-19 patients recovered from severe illness [32].”
From Effects of short-term breathing exercises on respiratory recovery in patients with COVID-19: a quasi-experimental study (2022) · cites this paper as [32]
In the citing paper
“Nevertheless, what emerges from preliminary data is the negative impact of long COVID on quality of life and its effects on patient work ability and social relationships [1,4,19].”
From Female gender is associated with long COVID syndrome: a prospective cohort study (2022) · cites this paper as [1]
In the citing paper
“These symptoms can endure up to 6–7 months and even longer [[1], [2], [3], [4], [5]].”
From Female gender is associated with long COVID syndrome: a prospective cohort study (2022) · cites this paper as [1]
In the citing paper
“Advanced age was associated with ongoing fatigue and musculoskeletal pain, or impairment in pulmonary functions, reflecting a decline in organ function and a slower ability to recover [1,16].”
From Female gender is associated with long COVID syndrome: a prospective cohort study (2022) · cites this paper as [1]
In the citing paper
“Literature data are not equivocal about the association between females and long COVID: some preliminary studies have shown an increased prevalence of fatigue [24] or other symptoms among women [1,5,13,16], while in other studies no gender association was found [4,[18], [19], [20]].”
From Female gender is associated with long COVID syndrome: a prospective cohort study (2022) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795
Standardization of Spirometry, 1994 Update. American Thoracic Society
(1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.3.7663792 · Cited by 6,605
EQ-SD: a measure of health status from the EuroQol Group
Rabin, R., & Charro, F. D. (2001) · Annals of Medicine · doi:10.3109/07853890109002087 · Cited by 5,613
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,258
Self-citationWiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J., & Prescott, H. C. (2020) · JAMA · doi:10.1001/jama.2020.12839 · Cited by 4,609
Persistent Symptoms in Patients After Acute COVID-19
Carfì, A., Bernabei, R., Landi, F., & for the Gemelli Against COVID-19 Post-Acute Care Study Group (2020) · JAMA · doi:10.1001/jama.2020.12603 · Cited by 4,561
Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19)
Pan, F., Ye, T., Sun, P., Gui, S., Liang, B., Li, L., Zheng, D., Wang, J., Hesketh, R. L., Yang, L., et al. (2020) · Radiology · doi:10.1148/radiol.2020200370 · Cited by 2,915
Self-citation
Cited by
Sorted by citations
Items 701–800 of 1,004
Cui, G., Rao, B., Zeng, Z.-H., Wang, X., Ren, T., Wang, H., Luo, H., Ren, H., Liu, C., Ding, S., et al. (2022) · Military Medical Research · doi:10.1186/s40779-022-00387-y · Cited by 46
A Short Corticosteroid Course Reduces Symptoms and Immunological Alterations Underlying Long-COVID
Utrero‐Rico, A., Ruiz‐Ruigómez, M., Laguna‐Goya, R., Arrieta-Ortubay, E., Chivite‐Lacaba, M., González‐Cuadrado, C., Lalueza, A., Almendro-Vázquez, P., Serrano, A., Aguado, J. M., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9111540 · Cited by 47
Comelli, A., Viero, G., Bettini, G., Nobili, A., Tettamanti, M., Galbussera, A. A., Muscatello, A., Mantero, M., Canetta, C., Boneschi, F. M., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.834354 · Cited by 46
Sonnweber, T., Tymoszuk, P., Sahanic, S., Boehm, A., Pizzini, A., Luger, A. K., Schwabl, C., Nairz, M., Grubwieser, P., Kurz, K., et al. (2022) · eLife · doi:10.7554/elife.72500 · Cited by 47
COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity
Lundstrom, K. H., Hromić‐Jahjefendić, A., Bilajac, E., Aljabali, A. A. A., Baralić, K., Sabri, N. A., Shehata, E. M., Raslan, M., Ferreira, A. C. B. H., Orlandi, L., et al. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110495 · Cited by 46
González-Aumatell, A., Bovo, M. V., Carreras‐Abad, C., Cuso-Perez, S., Marsal, È. D., Coll-Fernández, R., Goicoechea-Calvo, A., Giralt‐López, M., Cantallops, A. E., Morón‐López, S., et al. (2022) · Children · doi:10.3390/children9111677 · Cited by 45
Schlemmer, F., Valentin, S., Boyer, L., Guillaumot, A., Chabot, F., Dupin, C., Guen, P. L., Lorillon, G., Bergeron, A., Basille, D., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.01532-2022 · Cited by 45
Thapaliya, K., Marshall‐Gradisnik, S., Barth, M., Eaton-Fitch, N., & Barnden, L. R. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1125208 · Cited by 50
Lemhöfer, C., Sturm, C., Loudovici-Krug, D., Guntenbrunner, C., Bülow, M., Reuken, P. A., Quickert, S., & Best, N. (2023) · Quality of Life Research · doi:10.1007/s11136-023-03369-2 · Cited by 45
Ioannou, G. N., Berry, K., Rajeevan, N., Li, Y., Mutalik, P., Yan, L., Bui, D. P., Cunningham, F. E., Hynes, D. M., Rowneki, M., et al. (2023) · Annals of Internal Medicine · doi:10.7326/m23-1394 · Cited by 47
Self-citationAschman, T., Wyler, E., Baum, O., Hentschel, A., Legler, F., Preuße, C., Meyer‐Arndt, L., Büttnerova, I., Förster, A., Cengiz, D., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01662-2 · Cited by 48
Brehon, K., Miciak, M., Hung, P., Chen, S., Perreault, K., Hudon, A., Wieler, M., Hunter, S., Hoddinott, L., Hall, M., et al. (2023) · BMC Health Services Research · doi:10.1186/s12913-023-10288-y · Cited by 50
Chagas, L. D. S., & Serfaty, C. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073819 · Cited by 50
Rossato, M. S., Brilli, E., Ferri, N., Giordano, G., & Tarantino, G. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.08.031 · Cited by 48
Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistencePreprint
Talla, A., Vasaikar, S. V., Lemos, M. P., Moodie, Z., Pebworth, M.-P., Henderson, K. E., Cohen, K. W., Czartoski, J., Lai, L., Suthar, M. S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.26.442666 · Cited by 46
Self-citationPost-COVID syndrome: A reflection and opinion paper
Bouza, E., Cantón, R., Ramos, P. D. L., Botella, A. G., García‐Lledó, A., Gómez‐Pavón, J., del Castillo, J. M. G., Hernández‐Sampelayo, T., Delgado, M. C. M., Martín‐Sánchez, F. J., et al. (2021) · Revista Española de Quimioterapia · doi:10.37201/req/023.2021 · Cited by 44
Long COVID, neuropsychiatric disorders, psychotropics, present and future
Tang, S. W., Leonard, B. E., & Helmeste, D. M. (2022) · Acta Neuropsychiatrica · doi:10.1017/neu.2022.6 · Cited by 45
Brain Imaging Changes in Patients Recovered From COVID-19: A Narrative Review
Huang, Y., Ling, Q., Manyande, A., Wu, D., & Xiang, B. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.855868 · Cited by 44
Badinlou, F., Lundgren, T., & Jansson‐Fröjmark, M. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04405-0 · Cited by 52
Post-COVID-19 syndrome and quality of life impairment in severe COVID-19 Mexican patients
Román-Montes, C. M., Flores-Soto, Y. C., Guaracha-Basáñez, G. A., Tamez-Torres, K. M., Sifuentes‐Osornio, J., González-Lara, M. F., & Ponce‐de‐León, A. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1155951 · Cited by 50
Weber, B., Siddiqi, H. K., Zhou, G., Vieira, J. L., Kim, A., Rutherford, H., Mitre, X., Feeley, M., Oganezova, K., Varshney, A. S., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.022010 · Cited by 44
Caring for older adults during the COVID-19 pandemic
Prendki, V., Tiseo, G., & Falcone, M. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.02.040 · Cited by 45
Plasma proteomic and metabolomic characterization of COVID-19 survivors 6 months after discharge
Li, H., Li, X., Wu, Q., Wang, X., Qin, Z., Wang, Y., He, Y., Wu, Q., Li, L., & Chen, H. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04674-3 · Cited by 45
Self-citationElkan, M., Dvir, A., Zaidenstein, R., Keller, M., Kagansky, D., Hochman, C., & Koren, R. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s323316 · Cited by 43
Sibila, O., Perea, L., Albacar, N., Moisés, J., Cruz, T., Mendoza, N., Solarat, B., Lledó, G. M., Espinosa, G., Barberà, J. A., et al. (2022) · Respiratory Research · doi:10.1186/s12931-022-01955-5 · Cited by 44
Effects of SARS-CoV-2 Inflammation on Selected Organ Systems of the Human Body
Kopańska, M., Barnaś, E., Błajda, J., Kuduk, B., Łagowska, A., & Banaś-Ząbczyk, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084178 · Cited by 45
Abdel‐Moneim, A., Radwan, M. A., & Yousef, A. I. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2078081 · Cited by 45
Local anesthetics as a therapeutic tool for post COVID-19 patients: A case report
Vinyes, D., Muñoz-Sellart, M., & Caballero, T. G. (2022) · Medicine · doi:10.1097/md.0000000000029358 · Cited by 43
T cell perturbations persist for at least 6 months following hospitalization for COVID-19
Govender, M., Hopkins, F. R., Göransson, R., Svanberg, C., Shankar, E. M., Hjorth, M., Nilsdotter‐Augustinsson, Å., Sjöwall, J., Nyström, S. N., & Larsson, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.931039 · Cited by 43
Scaramuzzo, G., Ronzoni, L., Campo, G. C., Priani, P., Arena, C., Rosa, R. L., Turrini, C., Volta, C. A., Papi, A. A., Spadaro, S., et al. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-02214-5 · Cited by 43
Musculoskeletal complications in long COVID-19: A systematic review
Swarnakar, R., Jenifa, S., & Wadhwa, S. (2022) · World Journal of Virology · doi:10.5501/wjv.v11.i6.485 · Cited by 45
Du, Y., Zhao, W., Huang, S., Huang, Y., Chen, Y., Zhang, H., Guo, H., & Liu, J. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114969 · Cited by 46
Piva, T., Masotti, S., Raisi, A., Zerbini, V., Grazzi, G., Mazzoni, G., Murri, M. B., & Mandini, S. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.12.155 · Cited by 43
Manganotti, P., Michelutti, M., Furlanis, G., Deodato, M., & Stella, A. B. (2023) · Clinical Neurophysiology · doi:10.1016/j.clinph.2023.04.010 · Cited by 43
Role of Endothelium in Cardiovascular Sequelae of Long COVID
Santoro, L., Zaccone, V., Falsetti, L., Ruggieri, V., Danese, M., Miro, C., Giorgio, A. D., Nesci, A., D’Alessandro, A., Moroncini, G., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11082239 · Cited by 45
Secuelas médicas de la COVID-19
Peramo-Álvarez, F. P., Zúñiga, M. Á. L., & López‐Ruz, M. Á. (2021) · Medicina Clínica · doi:10.1016/j.medcli.2021.04.023 · Cited by 55
18F-FDG-PET Imaging for Post-COVID-19 Brain and Skeletal Muscle Alterations
Rudroff, T., Workman, C. D., & Ponto, L. L. B. (2021) · Viruses · doi:10.3390/v13112283 · Cited by 44
Leitlinie S1: Long COVID: Differenzialdiagnostik und Behandlungsstrategien
Rabady, S., Altenberger, J., Brose, M., Denk‐Linnert, D., Fertl, E., Götzinger, F., Pellı́n, M. D. L. C., Hofbaur, B., Hoffmann, K., Hoffmann-Dorninger, R., et al. (2021) · Wiener klinische Wochenschrift · doi:10.1007/s00508-021-01974-0 · Cited by 46
Huntley, C., Patel, K. K., Bushra, S.-E.-S., Mobeen, F., Armitage, M. N., Pye, A., Knight, C. B., Mostafa, A., Kershaw, M., Mughal, A. Z., et al. (2022) · ERJ Open Research · doi:10.1183/23120541.00056-2022 · Cited by 43
Prampart, S., Gentil, S. L., Bureau, M. L., Macchi, C., Leroux, C., Chapelet, G., de Decker, L., Rouaud, A., & Boureau, A. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03197-y · Cited by 43
Multidisciplinary approach for post-acute COVID-19 syndrome: time to break down the walls
Montani, D., Savale, L., Beurnier, A., Colle, R., Noël, N., Pham, T. O., Monnet, X., & Humbert, M. J. C. (2021) · European Respiratory Journal · doi:10.1183/13993003.01090-2021 · Cited by 44
Exertional intolerance and dyspnea with preserved lung function: an emerging long COVID phenotype?
Lam, G. Y., Befus, A. D., Damant, R. W., Ferrara, G., Fuhr, D. P., Stickland, M. K., Varughese, R. A., Wong, E. Y. L., & Smith, M. P. (2021) · Respiratory Research · doi:10.1186/s12931-021-01814-9 · Cited by 42
Sun, G., Cui, Q., Garcia, G., Wang, C., Zhang, M., Arumugaswami, V., Riggs, A. D., & Shi, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-96462-w · Cited by 44
Self-citationAlba, G. A., Ziehr, D. R., Rouvina, J. N., Hariri, L. P., Knipe, R. S., Medoff, B. D., Hibbert, K. A., Kowal, A., Hoenstine, C., Ginns, L. C., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101066 · Cited by 44
One‐year mortality and consequences of COVID ‐19 in cancer patients: A cohort study
Chai, C., Feng, X., Lü, M., Li, S., Chen, K., Wang, H., Wang, W., Tang, Z., Cheng, G., Wu, X., et al. (2021) · IUBMB Life · doi:10.1002/iub.2536 · Cited by 42
Self-citationNakhli, R. E., Shanker, A., Sarosiek, I., Boschman, J., Espino, K., Sigaroodi, S., Al-Bayati, I., Elhanafi, S. E., Sadeghi, A., Sarosiek, J., et al. (2022) · Neurogastroenterology & Motility · doi:10.1111/nmo.14368 · Cited by 42
Sobrino-Relaño, S., Balboa-Bandeira, Y., Peña, J., Ibarretxe‐Bilbao, N., Zubiaurre‐Elorza, L., & Ojeda, N. (2023) · Scientific Reports · doi:10.1038/s41598-023-37420-6 · Cited by 45
Townsend, L., Dyer, A. H., McCluskey, P., O’Brien, K., Dowds, J., Laird, E. J., Bannan, C., Bourke, N. M., Cheallaigh, C. N., Byrne, D., et al. (2021) · Nutrients · doi:10.3390/nu13072430 · Cited by 44
Lifestyle Adjustments in Long-COVID Management: Potential Benefits of Plant-Based Diets
Storz, M. A. (2021) · Current Nutrition Reports · doi:10.1007/s13668-021-00369-x · Cited by 45
Respiratory Complications after COVID-19
Al-Jahdhami, I., Al-naamani, K., Al‐Mawali, A., & Bennji, S. M. (2021) · Oman Medical Journal · doi:10.5001/omj.2022.52 · Cited by 42
Understanding how Victoria, Australia gained control of its second COVID-19 wave
Trauer, J. M., Lydeamore, M., Dalton, G. W., Pilcher, D. V., Meehan, M. T., McBryde, E. S., Cheng, A. C., Sutton, B. A., & Ragonnet, R. R. (2021) · Nature Communications · doi:10.1038/s41467-021-26558-4 · Cited by 44
Garout, M. A., Saleh, S. A. K., Adly, H. M., Abdulkhaliq, A. A., Khafagy, A. A., Abdeltawab, M. R., Rabaan, A. A., Rodriguez-Morales, A. J., Al‐Tawfiq, J. A., & Alandiyjany, M. N. (2022) · Infection · doi:10.1007/s15010-022-01788-w · Cited by 46
COVID‐19 metabolism: Mechanisms and therapeutic targets
Wang, T., Cao, Y., Zhang, H., Wang, Z., Man, C. H., Yang, Y., Chen, L., Xu, S., Yan, X., Zheng, Q., et al. (2022) · MedComm · doi:10.1002/mco2.157 · Cited by 42
Self-citationGoldhaber, N. H., Kohn, J. N., Ogan, W. S., Sitapati, A. M., Longhurst, C., Wang, A. Y., Lee, S., Hong, S., & Horton, L. E. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192416841 · Cited by 43
Norrefalk, J., Borg, K., & Bilevičiūtė-Ljungar, I. (2021) · Journal of Rehabilitation Medicine · doi:10.2340/jrm.v53.188 · Cited by 41
Besutti, G., Monelli, F., Schirò, S., Milone, F., Ottone, M., Spaggiari, L., Facciolongo, N. C., Salvarani, C., Croci, S., Pattacini, P., et al. (2022) · Tomography · doi:10.3390/tomography8030097 · Cited by 41
Patel, U. K., Mehta, N. N., Patel, A., Patel, N., Ortíz, J. F., Khurana, M., Urhoghide, E., Parulekar, A., Bhriguvanshi, A., Patel, N., et al. (2022) · Cureus · doi:10.7759/cureus.29694 · Cited by 41
The relationship between chronic immune response and neurodegenerative damage in long COVID-19
Elizalde-Díaz, J. P., Miranda-Narváez, C. L., Martínez‐Lazcano, J. C., & Martínez‐Martínez, E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1039427 · Cited by 43
Sansone, D., Tassinari, A., Valentinotti, R., Kontogiannis, D., Ronchese, F., Centonze, S., Maggiore, A., Cegolon, L., & Filon, F. L. (2022) · Life · doi:10.3390/life13010097 · Cited by 42
Ahmad, A. V. D., Khan, S. W., Ali, S., & Yasar, Q. (2024) · Scientific Reports · doi:10.1038/s41598-024-58877-z · Cited by 41
Cardiovascular disease and covid-19: A systematic review
Krishna, B. A., Metaxaki, M., Sithole, N., Jiménez, P. L., Martín, P., & Salinas-Botrán, A. (2024) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2024.101482 · Cited by 45
Heidbreder, A., Sonnweber, T., Stefani, A., Ibrahim, A., Cesari, M., Bergmann, M., Brandauer, E., Tancevski, I., Löffler‐Ragg, J., & Högl, B. (2021) · Sleep Medicine · doi:10.1016/j.sleep.2021.01.051 · Cited by 41
Otsuka, Y., Tokumasu, K., Nakano, Y., Honda, H., Sakurada, Y., Sunada, N., Omura, D., Hasegawa, K., Hagiya, H., Obika, M., et al. (2021) · Cureus · doi:10.7759/cureus.18568 · Cited by 41
McFann, K., Baxter, B. A., LaVergne, S. M., Stromberg, S., Berry, K., Tipton, M., Haberman, J., Ladd, J., Webb, T. L., Dunn, J., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182111048 · Cited by 43
Pulmonary surfactant as a versatile biomaterial to fight COVID-19
Herman, L., Smedt, S. C. D., & Raemdonck, K. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.023 · Cited by 42
Longitudinal Plasma Proteomics Analysis Reveals Novel Candidate Biomarkers in Acute COVID-19
Mohammed, Y., Goodlett, D. R., Cheng, M. P., Vinh, D. C., Lee, T. C., McGeer, A., Sweet, D. D., Tran, K. C., Lee, T., Murthy, S., et al. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00863 · Cited by 41
One Year Overview and Follow-Up in a Post-COVID Consultation of Critically Ill Patients
González, J., Zuil, M., Benitez, I. D., de Gonzalo‐Calvo, D., Aguilar, M. D. L. M. V.-P., Santisteve, S., Vaca, R., Mínguez, O., Seck, F., Torres, G., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.897990 · Cited by 41
Multicenter analysis of neutrophil extracellular trap dysregulation in adult and pediatric COVID-19
Carmona‐Rivera, C., Zhang, Y., Dobbs, K., Markowitz, T. E., Dalgard, C. L., Oler, A. J., Claybaugh, D., Draper, D. L., Truong, M., Delmonte, O. M., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.160332 · Cited by 41
Battistella, L. R., Imamura, M., Pretto, L. R. D., Cauwenbergh, S. K. H. A. A. V., Ramos, V. D., Uchiyama, S. S. T., Matheus, D., Kuhn, F., de Oliveira, A. A. A., Naves, G. S., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-057246 · Cited by 41
Versace, V., Ortelli, P., Dezi, S., Ferrazzoli, D., Alibardi, A., Bonini, I., Engl, M., Maestri, R., Assogna, M., Ajello, V., et al. (2022) · Clinical Neurophysiology · doi:10.1016/j.clinph.2022.10.017 · Cited by 42
Rutkowski, S., Bogacz, K., Czech, O., Rutkowska, A., & Szczegielniak, J. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192416980 · Cited by 44
Postintensive Care Syndrome-Family Associated With COVID-19 Infection
Shirasaki, K., Hifumi, T., Isokawa, S., Hashiuchi, S., Tanaka, S., Yanagisawa, Y., Takahashi, O., & Otani, N. (2022) · Critical Care Explorations · doi:10.1097/cce.0000000000000725 · Cited by 40
Buonsenso, D., Gualano, M. R., Rossi, M. F., Gris, A. V., Sisti, L. G., Borrelli, I., Santoro, P. E., Tumminello, A., Gentili, C., Malorni, W., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191711093 · Cited by 40
Brain hypoxia, neurocognitive impairment, and quality of life in people post-COVID-19
Adingupu, D. D., Soroush, A., Hansen, A., Twomey, R., & Dunn, J. F. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11767-2 · Cited by 46
Cumpstey, A. F., Clark, A. D., Santolini, J., Jackson, A. A., & Feelisch, M. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0017 · Cited by 40
Aging and respiratory viral infection: from acute morbidity to chronic sequelae
Wu, Y., Goplen, N. P., & Sun, J. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00624-2 · Cited by 42
Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles
Wu, C., Xu, Q., Wang, H., Tu, B., Zeng, J., Zhao, P., Shi, M., Qiu, H. Y., & Huang, Y. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.004 · Cited by 43
Strategies to evaluate outcomes in long-COVID-19 and post-COVID survivors
Crispo, A., Bimonte, S., Porciello, G., Forte, C. A., Cuomo, G., Montagnese, C., Prete, M., Grimaldi, M., Celentano, E., Amore, A., et al. (2021) · Infectious Agents and Cancer · doi:10.1186/s13027-021-00401-3 · Cited by 42
The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19
Whittington, M. D., Pearson, S. D., Rind, D. M., & Campbell, J. D. (2022) · Value in Health · doi:10.1016/j.jval.2021.11.1378 · Cited by 40
Figueiredo, E. A. B., Silva, W. T., Tsopanoglou, S. P., Vitorino, D. F. D. M., de Oliveira, L. F. L., Silva, K. L. S., Luz, H. D. H., Ávila, M. R., de Oliveira, L. F. F., Lacerda, A. C. R., et al. (2022) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0741-2021 · Cited by 40
Lv, Y., Zhang, T., Cai, J., Huang, C., Zhan, S., & Liu, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.952987 · Cited by 40
Self-citationFrontera, J. A., Sabadia, S. B., Yang, D., de Havenon, A., Yaghi, S. R., Lewis, A. K., Lord, A. S., Melmed, K. R., Thawani, S. P., Balcer, L. J., et al. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120487 · Cited by 42
COVID-19 as a Risk Factor for Alzheimer’s Disease
Golzari-Sorkheh, M., Weaver, D. F., & Reed, M. A. (2023) · Journal of Alzheimer's Disease · doi:10.3233/jad-220800 · Cited by 39
Fajar, J. K., Ilmawan, M., Mamada, S. S., Mutiawati, E., Husnah, M., Yusuf, H., Nainu, F., Sirinam, S., Keam, S., Ophinni, Y., et al. (2021) · Narra J · doi:10.52225/narra.v1i3.48 · Cited by 39
Rahmati, M., Shamsi, M. M., Woo, W., Koyanagi, A., Lee, S. W., Yon, D. K., Shin, J. I., & Smith, L. (2023) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2023.01.003 · Cited by 39
A patient-centric modeling framework captures recovery from SARS-CoV-2 infection
Ruffieux, H., Hanson, A., Lodge, S., Lawler, N. G., Whiley, L., Gray, N., Nolan, T. H., Bergamaschi, L., Mescia, F., Turner, L., et al. (2023) · Nature Immunology · doi:10.1038/s41590-022-01380-2 · Cited by 40
Mild SARS-CoV-2 infection results in long-lasting microbiota instability
Upadhyay, V., Suryawanshi, R. K., Tasoff, P., McCavitt-Malvido, M., Kumar, R., Murray, V., Noecker, C. A., Bisanz, J. E., Hswen, Y., Ha, C. W. Y., et al. (2023) · mBio · doi:10.1128/mbio.00889-23 · Cited by 40
Filho, A. J. M. C., Braniff, O., Angelova, A., Deng, Y., & Tremblay, M. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110702 · Cited by 41
Kerzhner, O., Berla, E., Har‐Even, M., Ratmansky, M., & Goor‐Aryeh, I. (2023) · Pain Practice · doi:10.1111/papr.13277 · Cited by 44
New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic
Carvajal, J. J., García-Castillo, V., Cuellar, S. V., Campillay-Véliz, C. P., Salazar‐Ardiles, C., Avellaneda, A. M., Muñoz, C. A., Retamal-Díaz, A. R., Bueno, S. M., González, P. A., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1363572 · Cited by 42
Neurological complications caused by SARS-CoV-2
Pang, Z., Tang, A., He, Y., Fan, J., Yang, Q., Tong, Y., & Fan, H. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00131-24 · Cited by 41
Rando, H. M., MacLean, A. L., Lee, A. J., Lordan, R., Ray, S., Bansal, V., Skelly, A. N., Sell, E., Dziak, J. J., Shinholster, L., et al. (2021) · mSystems · doi:10.1128/msystems.00095-21 · Cited by 42
Self-citationEffects of the COVID-19 Pandemic on Mental Health in Peru: Psychological Distress
Ruíz-Frutos, C., Baldeón, J. C. P., Ortega‐Moreno, M., Guardia, M. D. C. V., Días, A., Bernardes, J. M., & Gómez-Salgado, J. C. (2021) · Healthcare · doi:10.3390/healthcare9060691 · Cited by 39
Age-Associated Neurological Complications of COVID-19: A Systematic Review and Meta-Analysis
Sullivan, B. N., & Fischer, T. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.653694 · Cited by 40
Bašić‐Jukić, N., Jurić, I., Furić-Čunko, V., Katalinić, L., Radić, J., Bošnjak, Z., Jelaković, B., & Kaštelan, Ž. (2021) · Immunity Inflammation and Disease · doi:10.1002/iid3.509 · Cited by 39
de Castilhos, J., Zamir, E., Hippchen, T., Rohrbach, R., Schmidt, S., Hengler, S., Schumacher, H., Neubauer, M., Kunz, S., Müller-Esch, T., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab902 · Cited by 39
Yoon, S., Goh, H., Chan, A. W.-M., Malhotra, R., Visaria, A., Matchar, D. B., Lum, E., Seng, B., Ramakrishnan, C., Quah, S. R., et al. (2021) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2021.11.004 · Cited by 39
Post-acute COVID-19 syndrome: a new tsunami requiring a universal case definition
Lledó, G. M., Sellarés, J., Brotons, C., Sans-Corrales, M., Antón, J. D., Blanco, J., Bassat, Q., Sarukhan, A., Miró, J. M., de Sanjosé, S., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.11.015 · Cited by 42
Domenico, L. D., Sabbatini, C. E., Boëlle, P., Poletto, C., Crépey, P., Paireau, J., Cauchemez, S., Beck, F., Noël, H., Lévy-Bruhl, D., et al. (2021) · Communications Medicine · doi:10.1038/s43856-021-00057-5 · Cited by 46
The year in cardiovascular medicine 2021: heart failure and cardiomyopathies
Bauersachs, J. K., de Boer, R. A., Lindenfeld, J. M., & Bozkurt, B. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab887 · Cited by 39
Metadata
- Authors
- Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., Kang, L., Guo, L., Liu, M., Zhou, X., Luo, J., Huang, Z., Tu, S., Zhao, Y., Chen, L., Xu, D., Li, Y., Li, C., Peng, L., Li, Y., Xie, W., Cui, D., Shang, L., Fan, G., Xu, J., Wang, G., Wang, Y., Zhong, J., Wang, C., Wang, J., Zhang, D., & Cao, B.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Capital Medical University (CN)
- China-Japan Friendship Hospital (CN)
- Jinyintan Hospital (CN)
- Peking University (CN)
- Harbin Medical University (CN)
- Beijing University of Chinese Medicine (CN)
- Tsinghua University (CN)
- Corresponding author
- Cao, Bin
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 397
- Issue
- 10270
- Pages
- 220-232
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC7833295
- OpenAlex
- W3120387768
- Cited by
- 4,084
- References
- 41
- Citations by year
- 2026: 67 · 2025: 180 · 2024: 510 · 2023: 934 · 2022: 1300 · 2021: 1088
- FWCI
- 458.37
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- bronze
- doi.org
- Locations
- The Lancet (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science and Technology Major Project (2020ZX09201001)
- Chinese Academy of Medical Sciences (2020-I2M-CoV19\u2013005)
- National Natural Science Foundation of China (82041011/H0104)
- National Key Research and Development Program of China (2018YFC1200102)
- China-Japan Friendship Hospital
- Topics
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- COVID-19 pandemic, long-term health effects, long COVID, fatigue, muscle weakness, sleep disorders, anxiety, depression, disease severity, health-related quality of life, physical function, lung function, SARS-CoV-2, retraction, Wuhan, post-discharge follow-up, risk factors, lopinavir
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Serological Testing, Post-Acute COVID-19 Syndrome, Aged, China, Fatigue, Female, Humans, Length of Stay, Male, Middle Aged, Quality of Life, Surveys and Questionnaires, Severity of Illness Index, Sleep Wake Disorders, Cohort Studies, Comorbidity, Muscle Weakness, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
